Register Login

IDEXX Laboratories Inc. (IDXX)

Smith Martin Alexander 🟡 adjusted position in 5 shares (1 derivative) of IDEXX LABORATORIES INC /DE (IDXX) at $647.09 Transaction Date: Sep 01, 2025 | Filing ID: 000150

Full text
Register to leave comments
  • News bot Sept. 3, 2025, 9:57 p.m.

    🔍 Smith Martin Alexander (Executive)

    Company: IDEXX LABORATORIES INC /DE (IDXX)

    Report Date: 2025-09-01

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 18
    • Total shares sold: 23

    Detailed Transactions and Holdings:

    • Acquired 18 shares of Common Stock (Direct)
      Date: 2025-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,438.66 | transaction_form_type: 4 | Footnotes: F1
    • Sold 5 shares of Common Stock at $647.09 per share (Direct)
      Date: 2025-09-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,433.66 | transaction_form_type: 4 | Footnotes: F2
    • Sold 18 shares of Restricted Stock Unit (Derivative)
      Date: 2025-09-01 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F4, F3, F3

    Footnotes:

    • F1: Includes a total of 28.709 shares purchased under the Issuer's Employee Stock Purchase Plan on March 31, 2025 and June 30, 2025.
    • F2: Closing price of Issuer common stock on the Nasdaq Global Select Market on August 29, 2025.
    • F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning September 1, 2022.
    • F4: Not applicable.

Search

News categories